Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.29−0.44 (-6.54%)
Close on Nov 16, 2026Market cap $283.18MP/E –Yield –
Agenus ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Agenus's ebitda for the twelve months ending Jun 30, 2026 was $40.93M. For fiscal 2025 it was -$10.17M. The highest annual figure on record is $32.54M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.17M | – |
| FY2024 | Dec 31, 2024 | -$107.13M | – |
| FY2023 | Dec 31, 2023 | -$145.96M | – |
| FY2022 | Dec 31, 2022 | -$172.48M | -630.1% |
| FY2021 | Dec 31, 2021 | $32.54M | – |
| FY2020 | Dec 31, 2020 | -$110.06M | – |
| FY2019 | Dec 31, 2019 | -$63.48M | – |
| FY2018 | Dec 31, 2018 | -$117.53M | – |
| FY2017 | Dec 31, 2017 | -$97.80M | – |
| FY2016 | Dec 31, 2016 | -$102.53M | – |
| FY2015 | Dec 31, 2015 | -$78.74M | – |
| FY2014 | Dec 31, 2014 | -$41.74M | – |
| FY2013 | Dec 31, 2013 | -$24.39M | – |
| FY2012 | Dec 31, 2012 | -$5.12M | – |
| FY2011 | Dec 31, 2011 | -$16.83M | – |
| FY2010 | Dec 31, 2010 | -$18.31M | – |
| FY2009 | Dec 31, 2009 | -$23.57M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $11.81M | – |
| Q1 FY2026 | Mar 31, 2026 | $15.64M | – |
| Q4 FY2025 | Dec 31, 2025 | $15.00M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.51M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.54M | – |
| Q1 FY2025 | Mar 31, 2025 | -$10.11M | – |
| Q4 FY2024 | Dec 31, 2024 | -$22.64M | -2363.6% |
| Q3 FY2024 | Sep 30, 2024 | -$28.16M | – |
| Q2 FY2024 | Jun 30, 2024 | -$26.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$29.51M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.00M | – |
| Q3 FY2023 | Sep 30, 2023 | -$43.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$51.69M | – |
| Q1 FY2023 | Mar 31, 2023 | -$51.78M | – |
| Q4 FY2022 | Dec 31, 2022 | -$55.87M | – |
| Q3 FY2022 | Sep 30, 2022 | -$39.94M | -121.1% |
| Q2 FY2022 | Jun 30, 2022 | -$42.88M | – |
| Q1 FY2022 | Mar 31, 2022 | -$33.80M | – |
| Q4 FY2021 | Dec 31, 2021 | -$52.37M | – |
| Q3 FY2021 | Sep 30, 2021 | $189.22M | – |
| Q2 FY2021 | Jun 30, 2021 | -$64.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$39.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$19.87M | – |
| Q3 FY2020 | Sep 30, 2020 | -$32.94M | – |
| Q2 FY2020 | Jun 30, 2020 | -$31.48M | – |
| Q1 FY2020 | Mar 31, 2020 | -$25.76M | -192.5% |
| Q4 FY2019 | Dec 31, 2019 | -$17.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$34.25M | – |
| Q2 FY2019 | Jun 30, 2019 | -$39.46M | – |
| Q1 FY2019 | Mar 31, 2019 | $27.85M | – |
| Q4 FY2018 | Dec 31, 2018 | -$37.88M | – |
| Q3 FY2018 | Sep 30, 2018 | -$24.44M | – |
| Q2 FY2018 | Jun 30, 2018 | -$15.02M | – |
| Q1 FY2018 | Mar 31, 2018 | -$40.19M | – |
| Q4 FY2017 | Dec 31, 2017 | -$28.55M | – |
| Q3 FY2017 | Sep 30, 2017 | -$30.16M | – |
| Q2 FY2017 | Jun 30, 2017 | -$27.36M | – |
| Q1 FY2017 | Mar 31, 2017 | -$11.73M | – |
| Q4 FY2016 | Dec 31, 2016 | -$18.39M | – |
| Q3 FY2016 | Sep 30, 2016 | -$35.09M | – |
See a number that looks wrong?